Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Kidney International|September 1, 1984
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokineticsJ S Gerig, N D Bolton, E A Swabb, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1980
Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunctionW K Bolton, W M Scheld, D A Spyker, et al.
Reviews of Infectious Diseases|November 1, 1985
Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritisW M Scheld, J P Brodeur, P A Foresman, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 6, 1999
Time course of hearing loss in an animal model of pneumococcal meningitisB W Kesser, G T Hashisaki, J H Spindel, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1982
Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitisW M Scheld, C Giampaolo, J Boyd, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Oral LY217896 for prevention of experimental influenza A virus infection and illness in humansF G Hayden, A R Tunkel, J J Treanor, et al.
Ear, Nose, & Throat Journal|May 11, 1992
Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitisT A Sydnor, W M Scheld, J Gwaltney, et al.
American Journal of Clinical Pathology|October 1, 1981
A multivariate approach to prognostication in experimental bacterial meningitisC Giampaolo, W M Scheld, J Savory, et al.
American Journal of Rhinology|September 9, 2000
Effects of fibrin sealant-containing antibiotics in a rabbit model of chronic sinusitisR J Schlosser, W D Spotnitz, G Rodeheaver, et al.
Infection|June 15, 2007
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic developmentB Spellberg, L G Miller, M N Kuo, et al.
Pageof 15